These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23918803)

  • 1. Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN.
    de Giorgio A; Krell J; Harding V; Stebbing J; Castellano L
    Mol Cell Biol; 2013 Oct; 33(20):3976-82. PubMed ID: 23918803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.
    Tay Y; Kats L; Salmena L; Weiss D; Tan SM; Ala U; Karreth F; Poliseno L; Provero P; Di Cunto F; Lieberman J; Rigoutsos I; Pandolfi PP
    Cell; 2011 Oct; 147(2):344-57. PubMed ID: 22000013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN ceRNA networks in human cancer.
    Poliseno L; Pandolfi PP
    Methods; 2015 May; 77-78():41-50. PubMed ID: 25644446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of competing endogenous RNAs of the tumor suppressor gene PTEN: A probabilistic approach.
    Zarringhalam K; Tay Y; Kulkarni P; Bester AC; Pandolfi PP; Kulkarni RV
    Sci Rep; 2017 Aug; 7(1):7755. PubMed ID: 28798471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs.
    Wang H; Radomska HS; Phelps MA;
    Elife; 2020 Oct; 9():. PubMed ID: 33073769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of mRNA 3'untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN.
    Roquid KAR; Alcantara KMM; Garcia RL
    Int J Oncol; 2020 Feb; 56(2):544-558. PubMed ID: 31894272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer.
    Zhang R; Guo Y; Ma Z; Ma G; Xue Q; Li F; Liu L
    Oncotarget; 2017 Apr; 8(16):26079-26089. PubMed ID: 28212532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.
    Karreth FA; Tay Y; Perna D; Ala U; Tan SM; Rust AG; DeNicola G; Webster KA; Weiss D; Perez-Mancera PA; Krauthammer M; Halaban R; Provero P; Adams DJ; Tuveson DA; Pandolfi PP
    Cell; 2011 Oct; 147(2):382-95. PubMed ID: 22000016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of computational methods for identifying miRNA-mediated RNA-RNA crosstalk.
    Li Y; Jin X; Wang Z; Li L; Chen H; Lin X; Yi S; Zhang Y; Xu J
    Brief Bioinform; 2019 Jul; 20(4):1193-1204. PubMed ID: 29077860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
    Liu H; Zhang L; Ding X; Sui X
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranscriptional Regulation of PTEN by Competing Endogenous RNAs.
    Tay Y; Pandolfi PP
    Methods Mol Biol; 2016; 1388():139-54. PubMed ID: 27033075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ceRNA in cancer: possible functions and clinical implications.
    Qi X; Zhang DH; Wu N; Xiao JH; Wang X; Ma W
    J Med Genet; 2015 Oct; 52(10):710-8. PubMed ID: 26358722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competing endogenous RNAs and cancer: How coding and non-coding molecules cross-talk can impinge on disease.
    Ala U
    Int J Biochem Cell Biol; 2021 Jan; 130():105874. PubMed ID: 33227395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of competing endogenous RNAs in gastric cancer.
    Hu Y; Tian H; Xu J; Fang JY
    Brief Funct Genomics; 2016 May; 15(3):266-73. PubMed ID: 26404556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression.
    Xia T; Chen S; Jiang Z; Shao Y; Jiang X; Li P; Xiao B; Guo J
    Sci Rep; 2015 Aug; 5():13445. PubMed ID: 26306906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Overview of the Computational Models Dealing with the Regulatory ceRNA Mechanism and ceRNA Deregulation in Cancer.
    Conte F; Fiscon G; Sibilio P; Licursi V; Paci P
    Methods Mol Biol; 2021; 2324():149-164. PubMed ID: 34165714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Complex Landscape of
    Sellars E; Gabra M; Salmena L
    Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31871240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing endogenous RNAs in lung cancer.
    Zhao M; Feng J; Tang L
    Cancer Biol Med; 2021 Feb; 18(1):1-20. PubMed ID: 33628581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing Endogenous RNAs (ceRNAs) in Colorectal Cancer: A Review.
    Akhbari MH; Zafari Z; Sheykhhasan M
    Expert Rev Mol Med; 2022 Jun; 24():e27. PubMed ID: 35748050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dickkopf-1 (DKK1) phosphatase and tensin homolog on chromosome 10 (PTEN) crosstalk via microRNA interference in the diabetic heart.
    Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Li Y; Li Y; Ye Y
    Basic Res Cardiol; 2013 May; 108(3):352. PubMed ID: 23636253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.